diabetes

A longitudinal cohort study found similar reduced rates of cancer development from patients that had either BMS or GLP-1 treatment.

To help clinicians monitor slow-healing chronic wounds, researchers created the iCares device and tested it in 20 people with a variety of wounds.

Two new FDA approvals and promising clinical trial results for drugs to treat diabetes and lung cancer, and more led the news this week.

Plummeting blood sugar can accelerate eye damage due to diabetes. Results in mice suggest that a new drug targeting hypoxia inducible factor could help.

Placental extracellular vesicles from maternal blood plasma identified women who would go on to develop complications later in their pregnancy.

GLP-1 agonists have transformed the treatment of type 2 diabetes and obesity, but they come with side effects. Physicians say the benefits outweigh the risks.

Targeting a gut bacterial species or its metabolites could potentially improve diabetes management by reducing sugar preferences. 

Injectable micelles that release glucagon could provide a new way to treat hypoglycemic events in diabetes.

Customizable hydrogels could make taking diabetes and cancer medications as well as other biologics easier for patients.

Once symptoms show up, it’s too late to cure many autoimmune diseases. Researchers are investigating ways to prevent the conditions from starting at all.